Patent Filing Timeline– A Living Record of Innovation and IP Protection
The Patent Filing Timeline serves as a living record of NOVA X QUANTUM intellectual property strategy. With multiple patent-pending technologies covering AI, blockchain, financial ecosystems, and robotics, NXQ ensures that its innovations remain exclusive, protected, and strategically licensed to the world’s leading enterprises.
NXQ’s patent strategy is designed to prevent unauthorized replication, ensuring that its groundbreaking technologies remain unmatched.

Patent Filing Timeline – Safeguarding Innovation, Securing the Future

A living record of NOVA X QUANTUM Inc.’s intellectual property strategy, ensuring exclusive protection and strategic licensing of AI, blockchain, financial, and robotics innovations.

scroll
01/13/2025
ParkBlockX™ Patent Filed
01/15/2025
Nova Nexus Blockchain™ Patent Filed
01/20/2025
NOVA XQ™ Patent Filed
01/21/2025
Nova Universal Framework™ Patent Filed
01/31/2025
StayChain™ Patent Filed
02/06/2025
CHAINRAILS™ Patent Filed
03/04/2025
INFINITE BANKING SYSTEM
03/31/2025
SOULVA™ Patent Filed
04/04/2025
NOVA 1000™ Patent Filed
04/21/2025
IMMORTAL LOGIC SYSTEM
February 2025
BetRails™ Patent Filed
05/19/2025
Dimensional Integrity Engine️️️™

NXQ’s Intellectual Property Strategy

NXQ’s patents ensure long-term exclusivity and market leadership across multiple industries.

Patents are structured for maximum global protection, preventing replication by competitors.

International filings will be completed after the first major licensing deal, ensuring efficient legal cost allocation.

Software coding and smart contracts are complete and ready for immediate deployment, adding immediate value to licensing partners.

How to Engage with NXQ’s Patents
NXQ’s patent portfolio is structured to secure the future of AI, blockchain, and financial systems. Investors, licensing partners, and industry leaders can review NXQ’s IP portfolio and explore opportunities for strategic collaboration. For inquiries about NXQ’s licensing opportunities, please contact us through our Investor Relations page.